share_log

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

揭開面紗:通過分析師洞察探索渤健公司
Benzinga ·  11/14 23:00
Throughout the last three months, 18 analysts have evaluated Biogen (NASDAQ:BIIB), offering a diverse set of opinions from bullish to bearish.
在過去的三個月裏,有18位分析師對渤健公司(納斯達克:BIIB)進行了評估,提出了從看好到看淡的多元化觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述,爲了全面了解過去30天的情緒變化並與前幾個月進行比較,提供了深入的見解。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $249.94, along with a high estimate of $300.00 and a low estimate of $180.00. Observing a downward trend, the current average is 6.41% lower than the prior average price target of $267.06.
分析師提供了更深入的見解,建立了12個月的價格目標,顯示平均目標爲249.94美元,高估爲300.00美元,低估爲180.00美元。觀察到價格呈下降趨勢,當前均值比之前的267.06美元的均值低了6.41%。
Exploring Analyst Ratings: An In...
分析師評級...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論